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Background
● Placebo response in clinical trials - “improvement in pain due to the 
psychological effect of receiving treatment”
● Drug effect is measured in clinical trials; Drug effect = Drug relief - Placebo 
relief
● High placebo response leads to “clinical trial failure” or a small drug effect
○ EXAMPLE: 
■ Drug relief: -5,
■ Placebo relief: -1 vs. -3
■ Drug effect: -4 and -2
Background (cont.)
● Current research aims to find correlates that predict placebo responders
● Pain variability: previously identified correlate of placebo response
● Previous research does not account for confounding variables 
(pre-intervention pain and natural history of disease)
Research Objectives
Derive the strength of the relationship between baseline pain variability and 
relief while controlling for the effects of pre-intervention pain and natural 
history between treatment groups.
Methods
● Used data from two clinical trials; both included no treatment (no_tx) and 
placebo groups, only one included a drug group (Placebo II)
● post ~ pre + group*sd (group is a factor, used for linear contrasts)
○ included pre-intervention pain as a covariate to control for pre-intervention pain
○ isolated effect by group to control for natural history by using linear contrasts
■ placebo improvement = no_tx + placebo
■ drug improvement = no_tx + placebo + drug
■ drug = drug improvement - placebo improvement = (no_tx + placebo + drug) - (no_tx + 
placebo) = drug
Methods (cont.)
● Calculated semipartial correlations using multiple regression model (post ~ 
pre + group*sd)
○ variance accounted for by ONE variable; reduces confounding effects
rsp = semipartial r
t = t-statistic (of variability)
R2 = model coefficient of determination (global fit of the 
model)




No treatment (n = 18) −0.16 (−0.39, 0.08)
Placebo (n=43) 0.13 (−0.08, 0.37)
Placebo II
No treatment (n=11) 0.08 (−0.11, 0.31)
Placebo (n=32) 0.01 (−0.15, 0.20)
Drug (n=30) −0.11 (−0.26, 0.06)
Results (cont.)
Conclusions
The relationship between pain variability and relief is weak and inconsistent; 
should not be used as a univariate predictor of relief in any group of a clinical 
trial
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Sensitivity Analysis






No treatment (n = 
18) −0.33 (−0.73, 0.23)
Placebo (n=43) 0.16 (−0.23, 0.45)
Placebo II
No treatment 
(n=11) 0.31 (−0.80, 0.79)
Placebo (n=32) 0.28 (−0.09, 0.52)




No treatment (n = 
18) −0.30 (−0.61, 0.19)
Placebo (n=43) 0 (−0.37, 0.28)
Placebo II
No treatment 
(n=11) 0.68 (−0.20, 0.91)
Placebo (n=32) 0.22 (−0.16, 0.52)
Drug (n=30) −0.10 (−0.40, 0.42)
